New applications of alphavirus-based expression vectors.

M Boorsma1, D Koller, W A Renner

  • 1Cytos Biotechnology AG, Wagistrasse 21, CH-8952, Zurich-Schlieren, Switzerland.

Cytotechnology
|February 24, 2012
PubMed
Summary

Alphavirus vectors offer high-level protein production for gene therapy and vaccine development. New non-cytopathic and inducible vectors enhance bioprocess strategies and gene discovery.

Related Concept Videos